A Look into the Trends, Developments, and Challenges Faced by the World's Pharmacogenomics Industry.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c32812) has announced the addition of World Pharmacogenomics -- Future of Healthcare Industry 2009(TM) to their offering. The study on World Pharmacogenomics -- Future of Healthcare Industry 2009(TM) includes the identification of novel genomic targets for drug development, the clinical applications of genomics science, potential benefits of pharmacogenomics, effect of genetic variability on drug toxicity and efficacy. Importantly, this market research report integrate new developments in genomics and proteomics to clinical medicine, pharmacology, and therapeutics and assess the trends, developments and challenges that the industry faces. Topics Covered 1. ASSESSING PHARMACOGENOMICS TECHNOLOGY AND PHARMACEUTICAL INDUSTRY 1.1. THE PHARMACEUTICAL INDUSTRY TODAY 1.2. BLOCKBUSTER DRUG SALES BY PHARMACEUTICAL SECTOR (2005) 1.3. COST OF DRUG DISCOVERY AND PHARMACOGENOMICS 1.4. FUTURE OF PHARMACOGENOMICS IN DRUG DEVELOPMENT 2. GLOBAL MARKET FOR PHARMACOGENOMICS DEVICES AND DIAGNOSTIC TOOLS 2.1. MARKET FOR MICROARRAYS (2004-2009) 2.1.1 Types of Microarrays 2.1.2 Market Demand for Microarrays in Pharmacogenomics 2.2. MARKET FOR PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ARRAYS (2004-2009) 2.2.1 Types of PCR Array Technologies 2.2.2 Market Demand for PCR-Assays (2004-2009) 2.3. IN SITU In place. When something is "in situ," it is in its original location. ANALYSIS 3. DEMAND FOR PHARMACOGENOMICS TREATMENT, BY DISEASE APPLICATIONS (2004-2009) 3.1. CARDIOVASCULAR DISEASE Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease 3.2. BREAST CANCER 3.3. LEUKEMIA 3.4. HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 3.5. GENETIC RESISTANCE TESTING AND PHARMACOGENOMICS 4. PHARMACOGENOMICS PATENT ANALYSIS AND IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. 4.1. PHARMACOGENOMICS PATENTS, BY APPLICATION CATEGORY 4.2. PHARMACOGENOMICS PATENTS, BY DISEASE 4.3. PHARMACOGENOMICS PATENTS, BY REGIONAL DISTRIBUTION 5. PHARMACOGENOMICS RESEARCH AND APPLICATION, BY REGION 5.1. UNITED STATES 5.2. EUROPEAN UNION European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community 5.3. JAPAN 5.4. OTHER REGIONS 6. PHARMACOGENOMICS AND DRUG METABOLISM Drug Metabolism/Interactions Definition Drug metabolism is the process by which the body breaks down and converts medication into active chemical substances. Precautions Drugs can interact with other drugs, foods, and beverages. 6.1. DRUG METABOLISM BY CYTOCHROMES 6.2. P-450 ISOZYMES AND PHARMACEUTICALS 6.2.1 P450 Isozyme isozyme /iso·zyme/ (i´so-zim) one of the multiple forms in which an enzyme may exist in an organism or in different species, the various forms differing chemically, physically, or immunologically, but catalyzing the same reaction. CYP CYP In currencies, this is the abbreviation for the Cyprus Pound. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 3A 6.2.2 P450 Isozyme CYP2D6 6.2.3 P450 Isozyme CYP2C9 6.2.4 P450 Isozyme 2C19 6.2.5 P450 Isozyme 1A2 6.3. GLOBAL MARKET FOR AMPLICHIP ARRAYS 6.4. COMPETITION WITH PHENOTYPIC ASSAY 7. COMPANY PROFILES 7.1. AFFYMETRIX INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . 7.1.1 Sales Revenue by Region and Product Type, 2005 7.1.2 Research and Development Expenses 7.1.3 New Products Launches and Issues 7.2. AGILENT TECHNOLOGIES, INC. 7.2.1 Sales and Revenue, By Region and Types of Products 2004 7.2.2 Research And Development Expenses 7.2.3 New Product Launches and Initiatives 7.3. THIRD WAVE TECHNOLOGIES, INC 7.3.1 Sales and Revenue, By Region and Product Type 2004 7.3.2 Research and Development Revenues 7.3.3 Products Launches and Initiatives 7.4. NANOGEN INC. 7.4.1 Sales and Revenue, by Region and Product Type, 2004 7.4.2 Research and Development Revenues 7.4.3 Product Launches and Initiatives 7.5. OTHER COMPETITORS 7.5.1 Applied Biosystems 7.5.2 GE Healthcare 7.5.3 Sequenom Inc. 7.5.4 Molecular Devices Corporation 7.5.5 Illumina 7.5.6 Incyte Corporation 7.5.7 deCODE genetics, Inc. 7.5.8 Caliper caliper Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving. Life Sciences 7.5.9 Orchid BioSciences, Inc. 7.5.10 Beckman Coulter, Inc. 7.5.11 Quest Diagnostics Incorporated List of Tables: List of Figures: Companies Mentioned - Affymetrix Inc. - Agilent Technologies, Inc. - Third Wave Technologies, Inc - Nanogen Inc. - Applied Biosystems - GE Healthcare - Sequenom Inc. - Molecular Devices Corporation - Illumina - Incyte Corporation - deCODE genetics, Inc. - Caliper Life Sciences - Orchid BioSciences, Inc. - Beckman Coulter, Inc. - Quest Diagnostics Incorporated For more information visit http://www.researchandmarkets.com/reports/c32812 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion